UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Lancet neurology, 2016-06, Vol.15 (7), p.673-684

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease

Molecular neurodegeneration, 2016-01, Vol.11 (3), p.3-3, Article 3

2016

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

JAMA neurology, 2015-10, Vol.72 (10), p.1175

2015

Link zum Volltext

Verfügbarkeit prüfen

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease

Molecular neurodegeneration, 2014-11, Vol.9 (1), p.53-53

2014

Link zum Volltext

Verfügbarkeit prüfen

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

Alzheimer's research & therapy, 2016-10, Vol.8 (1), p.41-41, Article 41

2016

Link zum Volltext

Verfügbarkeit prüfen

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease

Alzheimer's research & therapy, 2019-09, Vol.11 (1), p.82-16, Article 82

2019

Link zum Volltext

Verfügbarkeit prüfen

Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons

Neurochemistry international, 2018-12, Vol.121, p.38-49

2018

Link zum Volltext

Verfügbarkeit prüfen

Full-length and C-terminal neurogranin in Alzheimer's disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays

Alzheimer's research & therapy, 2020-12, Vol.12 (1), p.168-168, Article 168

2020

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

Movement disorders, 2016-06, Vol.31 (6), p.898-905

2016

Link zum Volltext

Verfügbarkeit prüfen

Mass Spectrometric Analysis of Lewy Body-Enriched α‑Synuclein in Parkinson’s Disease

Journal of proteome research, 2019-05, Vol.18 (5), p.2109-2120

2019

Link zum Volltext

Verfügbarkeit prüfen

Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

Journal of Cerebral Blood Flow & Metabolism, 2016, Vol.36 (1), p.95-113

2016

Link zum Volltext

Verfügbarkeit prüfen

A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer’s Disease

Neuroscience, 2019-11, Vol.420, p.136-144

2019

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?

Neuroscience letters, 2009-02, Vol.450 (3), p.332-335

2009

Link zum Volltext

Verfügbarkeit prüfen

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease

Alzheimer's research & therapy, 2014-01, Vol.6 (3), p.25-25

2014

Link zum Volltext

Verfügbarkeit prüfen

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Multiple sclerosis, 2016-10, Vol.22 (12), p.1587-1595

2016

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

Alzheimer's & dementia, 2015-10, Vol.11 (10), p.1180-1190

2015

Link zum Volltext

Verfügbarkeit prüfen

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease

Dementia and geriatric cognitive disorders extra, 2011-01, Vol.1 (1), p.31-42

2011

Link zum Volltext

Verfügbarkeit prüfen

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

Proteomics. Clinical applications, 2017-12, Vol.11 (11-12), p.11-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals

Neurology, 2023-01, Vol.100 (3), p.e275

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method

Neurochemical research, 2011-11, Vol.36 (11), p.2029-2042

2011

Link zum Volltext

Verfügbarkeit prüfen

Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease

Journal of the neurological sciences, 2012-11, Vol.322 (1), p.192-196

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders

Dementia and geriatric cognitive disorders, 2013-01, Vol.36 (1-2), p.99

2013

Link zum Volltext

Verfügbarkeit prüfen

Explorative and targeted neuroproteomics in Alzheimer's disease

Biochimica et biophysica acta, 2015-07, Vol.1854 (7), p.769-778

2015

Link zum Volltext

Verfügbarkeit prüfen

Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease

Parkinsonism & related disorders, 2018-04, Vol.49, p.4-8

2018

Link zum Volltext

Verfügbarkeit prüfen

Transient Inflammation in Neurogenic Regions after Irradiation of the Developing Brain

Radiation research, 2009-01, Vol.171 (1), p.66-76

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(59)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Neurosciences
(33)
Humans
(28)
Neurovetenskaper
(28)
Neurosciences & Neurology
(27)
Cerebrospinal Fluid
(23)
Neurology
(22)
Female
(19)
Male
(19)
Aged
(18)
Alzheimer's Disease
(18)
Middle Aged
(18)
Clinical Neurology
(17)
Biomarkers - Cerebrospinal Fluid
(15)
Medicin Och Hälsovetenskap
(12)
Aged, 80 And Over
(11)
Alzheimer Disease - Cerebrospinal Fluid
(11)
Biomarkers
(11)
Mass Spectrometry
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease

Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons

Full-length and C-terminal neurogranin in Alzheimer's disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

Mass Spectrometric Analysis of Lewy Body-Enriched α‑Synuclein in Parkinson’s Disease

Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer’s Disease

Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals

Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method

Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders

Explorative and targeted neuroproteomics in Alzheimer's disease

Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease

Transient Inflammation in Neurogenic Regions after Irradiation of the Developing Brain

Suchergebnisse filtern